Long non‐coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization. Issue 2 (12th January 2016)

• Record Type: Journal Article
• Authors: Wang, Zhongzhi; Jinnin, Masatoshi; Nakamura, Kayo; Harada, Miho; Kudo, Hideo; Nakayama, Wakana; Inoue, Kuniko; Nakashima, Taiji; Honda, Noritoshi; Fukushima, Satoshi; Ihn, Hironobu
• Is Part Of: Experimental dermatology. Volume 25:Issue 2(2016)
• Page Start: 131
• Page End: 136
• Publication Date: 2016-01-12
• Subjects: extracellular matrix -- long non‐coding RNA -- systemic sclerosis; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/exd.12900
• Languages: English
• ISSNs: 0906-6705

Abstract

Abstract: Long non‐coding RNAs (lncRNAs) are thought to have various functions other than RNA silencing. We tried to evaluate the expression of lncRNAs in patients with systemic sclerosis (SSc) and determined whether lncRNAs controls collagen expression in dermal fibroblasts. lncRNA expression was determined by real‐time PCR and in situ hybridization. Protein and mRNA levels of collagen were analysed using immunoblotting and real‐time PCR. We found TSIX, one of the lncRNAs, was overexpressed in SSc dermal fibroblasts both in vivo and in vitro, which was inhibited by the transfection of transforming growth factor (TGF)‐β1 siRNA. TSIX siRNA reduced the mRNA expression of type I collagen in normal and SSc dermal fibroblasts, but not the levels of major disease‐related cytokines. In addition, TSIX siRNA significantly reduced type I collagen mRNA stability, but not protein half‐lives. Furthermore, we first investigated serum lncRNA levels in patients with SSc, and serum TSIX levels were significantly increased in SSc patients. TSIX is a new regulator of collagen expression which stabilizes the collagen mRNA. The upregulation of TSIX seen in SSc fibroblasts may result from activated endogenous TGF‐β signalling and may play a role in the constitutive upregulation of collagen in these cells. Further studies on the regulatory mechanism of tissue fibrosis by lncRNAs in SSc skin lead to a better understanding of the pathogenesis, new diagnostic methods by their serum levels and new therapeutic approaches using siRNAs.